• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部使用七氟醚治疗慢性静脉性溃疡时的疼痛和镇痛药物。

Pain and analgesic drugs in chronic venous ulcers with topical sevoflurane use.

机构信息

Department of Dermatology, Hospital Severo Ochoa, Madrid, Spain.

Department of Dermatology, Hospital Doce de Octubre, Madrid, Spain.

出版信息

J Vasc Surg. 2018 Sep;68(3):830-835. doi: 10.1016/j.jvs.2017.11.071. Epub 2018 Feb 13.

DOI:10.1016/j.jvs.2017.11.071
PMID:29452834
Abstract

OBJECTIVE

Pain in chronic venous ulcers (CVUs) notably increases with the usual cleaning of the wound. Chronic pain is usually poorly controlled even with the multiple analgesic treatments available. Analgesics can have different serious adverse effects and medical interactions in old patients with several comorbidities. This study reports the efficacy and safety of topical sevoflurane for treatment of pain in CVUs.

METHODS

We report a descriptive and retrospective study of 30 patients older than 65 years with painful CVUs refractory to conventional analgesic treatments. Patients received topical sevoflurane treatment before the usual cleaning of the ulcer. Cleaning visits with sevoflurane every 2 days for a period of 1 month were scheduled. We compared the visual analog scale results and analgesic drugs for cleaning with and without topical sevoflurane. The systemic pharmacokinetics of sevoflurane after topical application has not been determined.

RESULTS

Pain related to CVUs decreased with topical sevoflurane. Sevoflurane had an analgesic effect with latency time between 2 and 7 minutes. The duration of analgesia ranged between 8 and 18 hours. The time needed to take an analgesic treatment increased after application of sevoflurane. The use of other conventional analgesic drugs, including paracetamol, metamizole, nonsteroidal anti-inflammatory drugs, tramadol, and major opioids, was progressively reduced. The main local adverse effects were mild and transient, including heat, pruritus, and erythema. There were no systemic adverse effects.

CONCLUSIONS

Topical sevoflurane has an intense, fast, and long-lasting local analgesic effect with an adequate safety profile. It also diminishes the taking of other conventional analgesic drugs. Topical sevoflurane is an efficient and safe therapeutic alternative for refractory painful CVUs.

摘要

目的

慢性静脉溃疡(CVU)的疼痛会随着伤口的常规清洁而显著增加。即使有多种可用的镇痛治疗方法,慢性疼痛通常也控制不佳。对于患有多种合并症的老年患者,镇痛药可能会产生不同的严重不良反应和药物相互作用。本研究报告了局部七氟醚治疗 CVU 疼痛的疗效和安全性。

方法

我们报告了一项针对 30 名年龄大于 65 岁的有疼痛性 CVU 且对常规镇痛治疗无反应的患者的描述性和回顾性研究。患者在常规清洁溃疡前接受局部七氟醚治疗。计划每 2 天清洁一次,同时使用七氟醚,为期 1 个月。我们比较了使用和不使用局部七氟醚清洁时的视觉模拟量表(VAS)评分和镇痛药结果。尚未确定局部应用七氟醚后的全身药代动力学。

结果

CVU 相关疼痛在使用局部七氟醚后减轻。七氟醚有镇痛作用,潜伏期为 2-7 分钟。镇痛持续时间为 8-18 小时。使用七氟醚后,需要服用镇痛药的时间增加。其他常规镇痛药的使用,包括对乙酰氨基酚、甲灭酸、非甾体抗炎药、曲马多和主要阿片类药物,逐渐减少。主要局部不良反应为轻度且短暂,包括发热、瘙痒和红斑。没有全身不良反应。

结论

局部七氟醚具有强烈、快速和持久的局部镇痛作用,安全性良好。它还减少了其他常规镇痛药的使用。局部七氟醚是治疗难治性疼痛性 CVU 的有效且安全的治疗选择。

相似文献

1
Pain and analgesic drugs in chronic venous ulcers with topical sevoflurane use.局部使用七氟醚治疗慢性静脉性溃疡时的疼痛和镇痛药物。
J Vasc Surg. 2018 Sep;68(3):830-835. doi: 10.1016/j.jvs.2017.11.071. Epub 2018 Feb 13.
2
Healing of chronic venous ulcer with topical sevoflurane.局部应用七氟醚治疗慢性静脉性溃疡。
Int Wound J. 2017 Dec;14(6):1323-1326. doi: 10.1111/iwj.12806. Epub 2017 Aug 17.
3
Pain, Quality of Life, and Functional Capacity With Topical Sevoflurane Application for Chronic Venous Ulcers: A Retrospective Clinical Study.七氟醚局部应用于慢性静脉溃疡的疼痛、生活质量及功能能力:一项回顾性临床研究
EJVES Short Rep. 2017 Sep 14;36:9-12. doi: 10.1016/j.ejvssr.2017.08.001. eCollection 2017.
4
Topical sevoflurane for chronic venous ulcers infected by multi-drug-resistant organisms.局部七氟醚治疗多重耐药菌感染的慢性静脉溃疡。
Int Wound J. 2017 Dec;14(6):1388-1390. doi: 10.1111/iwj.12794. Epub 2017 Jul 23.
5
Analgesic effectiveness of topical sevoflurane to perform sharp debridement of painful wounds.局部七氟醚在进行疼痛伤口锐性清创时的镇痛效果。
J Vasc Surg. 2019 May;69(5):1532-1537. doi: 10.1016/j.jvs.2018.08.175. Epub 2019 Jan 3.
6
Topical sevoflurane for rescue analgesia in refractory pain due to chronic venous ulcers.局部使用七氟醚用于慢性静脉溃疡所致难治性疼痛的急救镇痛。
Emergencias. 2018;30(2):138.
7
Efficacy and safety of topical sevoflurane in the treatment of chronic skin ulcers.外用七氟醚治疗慢性皮肤溃疡的疗效与安全性。
Am J Health Syst Pharm. 2017 May 1;74(9):e176-e182. doi: 10.2146/ajhp151008.
8
Chronic venous ulcer treatment with topical sevoflurane.外用七氟烷治疗慢性静脉溃疡
Int Wound J. 2016 Oct;13(5):1060-2. doi: 10.1111/iwj.12474. Epub 2015 Jul 21.
9
Treatment of chronic venous ulcers with topical sevoflurane: a retrospective clinical study.外用七氟醚治疗慢性静脉溃疡:一项回顾性临床研究。
Br J Anaesth. 2017 Oct 1;119(4):846-847. doi: 10.1093/bja/aex269.
10
Chronic outpatient treatment with topical sevoflurane in patients with vascular ulcers.慢性门诊局部七氟醚治疗血管性溃疡患者。
Farm Hosp. 2024 Jan-Feb;48(1):34-37. doi: 10.1016/j.farma.2023.06.012. Epub 2023 Jul 21.

引用本文的文献

1
GRIN2B alleviates mid-gestational sevoflurane exposure-induced early differentiation of rat neural stem cells by interacting with KIF17.GRIN2B通过与KIF17相互作用减轻妊娠中期七氟醚暴露诱导的大鼠神经干细胞早期分化。
J Cell Commun Signal. 2025 Jun 24;19(2):e70024. doi: 10.1002/ccs3.70024. eCollection 2025 Jun.
2
Prevalence and Mechanisms of Itch in Chronic Wounds: A Narrative Review.慢性伤口瘙痒的患病率及机制:一项叙述性综述
J Clin Med. 2025 Apr 22;14(9):2877. doi: 10.3390/jcm14092877.
3
A randomised, double-blind, placebo-controlled study to determine the analgesic efficacy, safety and tolerability of VPX638 administered topically to painful wounds.
一项随机、双盲、安慰剂对照研究,以确定局部应用于疼痛伤口的VPX638的镇痛效果、安全性和耐受性。
Wound Repair Regen. 2025 Jan-Feb;33(1):e70008. doi: 10.1111/wrr.70008.
4
Letter to editor: Virtual reality as a promising method of pain relief in patients with venous leg ulcers.致编辑的信:虚拟现实作为缓解下肢静脉溃疡患者疼痛的一种有前景的方法。
Int Wound J. 2024 Nov;21(11):e70136. doi: 10.1111/iwj.70136.